Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mexicano Inst PetrolfiledCriticalMexicano Inst Petrol
Priority to MX1892689ApriorityCriticalpatent/MX172016B/en
Publication of MX172016BpublicationCriticalpatent/MX172016B/en
La presente invención se refiere a una composición de cemento dental de fosfato de zinc, que comprende una fase sólida y una fase líquida, caracterizada porque la fase sólida está constituída por 78 a 98 por ciento en peso de óxido de zinc, 5 a 15 por ciento en peso de óxido de magnesio; 1 a 2 por ciento en peso de sílice y 0.2 a 0.8 por ciento en peso de nitrato de bismuto y porque la fase líquida está constituída por: 50 a 65 por ciento en peso de ácido ortofosfórico; 7 a 9.5 por ciento en peso de hidróxido de aluminio y 25 a 44 por ciento en peso de óxido de zinc.The present invention relates to a zinc phosphate dental cement composition, comprising a solid phase and a liquid phase, characterized in that the solid phase consists of 78 to 98 weight percent zinc oxide, 5 to 15 per percent by weight of magnesium oxide; 1 to 2 weight percent silica and 0.2 to 0.8 weight percent bismuth nitrate and because the liquid phase consists of: 50 to 65 weight percent orthophosphoric acid; 7 to 9.5 weight percent of aluminum hydroxide and 25 to 44 weight percent of zinc oxide.
MX1892689A1989-12-271989-12-27
ZINC PHOSPHATE DENTAL CEMENT COMPOSITION AND PROCESS FOR ITS PREPARATION
MX172016B
(en)
6-, 1- and 2-substituted-1-carbapen-2-em-3-carboxylic acids, processes for the preparation of such compounds and pharmaceutical composition comprising such compounds
PHARMACEUTICAL COMPOSITION CONTAINING A MIXTURE OF COLLAGEN AND AN ANTISEPTIC AND/OR ANTI-INFLAMMATORY ACTIVE INGREDIENT AND PROCESS FOR PRODUCTION THEREOF.
Derivatives of 4,5-dihydro-4-oxofuran-2-carboxylic acid, especially for use as hypolipidemic agents, processes for their preparation, pharmaceutical compositions comprising them, tetrahydropyran-2,3,5-triones useful in the preparation of the said derivatives and a process for preparing these tetrahydropyran-2,3,5-triones